13F-HR: Axon Enterprise, Inc. Discloses $198.3 Million Investment in Cellebrite DI Ltd.

Axon Enterprise, Inc. reports holding $198.3 million in Cellebrite DI Ltd. Ordinary Shares as of December 31, 2024.

Summary

• Axon Enterprise, Inc. filed a Form 13F report for the quarter ended December 31, 2024.
• The report discloses holdings of Cellebrite DI Ltd. Ordinary Shares.
• The total value of the holding is $198,270,000.
• Axon Enterprise, Inc. holds 9,000,000 shares of Cellebrite DI Ltd.
• The filing indicates sole voting authority over these shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a disclosure of holdings. The size of the investment is notable, suggesting a degree of confidence, but the document itself is purely informational.

Positives

• The large investment suggests confidence in Cellebrite DI Ltd.'s future prospects.

Risks

• The value of the holding is subject to market fluctuations and the performance of Cellebrite DI Ltd.

Industry Context

This investment reflects potential strategic alignment between Axon, a provider of law enforcement technology, and Cellebrite, a digital intelligence solutions company.

Stakeholder Impact

• The investment could positively impact Cellebrite DI Ltd.'s shareholders.
• The investment could strengthen the partnership between Axon and Cellebrite, potentially benefiting both companies' customers.

Key Dates